These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 2669069)

  • 1. Oncogene structure, function, and expression in breast cancer.
    Yee LD; Kacinski BM; Carter D
    Semin Diagn Pathol; 1989 May; 6(2):110-25. PubMed ID: 2669069
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oncogene activation in malignant transformation: a study of H-ras in human breast cancer.
    Spandidos DA
    Anticancer Res; 1987; 7(5B):991-6. PubMed ID: 3435051
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increase of GKLF messenger RNA and protein expression during progression of breast cancer.
    Foster KW; Frost AR; McKie-Bell P; Lin CY; Engler JA; Grizzle WE; Ruppert JM
    Cancer Res; 2000 Nov; 60(22):6488-95. PubMed ID: 11103818
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Analysis of oncogene and its expression at cellular level].
    Hirohashi S
    Hum Cell; 1988 Mar; 1(1):17-9. PubMed ID: 3154011
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanism of carcinogenesis: the role of oncogenes, transcriptional enhancers and growth factors.
    Spandidos DA
    Anticancer Res; 1985; 5(5):485-98. PubMed ID: 3904595
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of growth factors and oncogenes in normal and tumor-derived human mammary epithelial cells.
    Zajchowski D; Band V; Pauzie N; Tager A; Stampfer M; Sager R
    Cancer Res; 1988 Dec; 48(24 Pt 1):7041-7. PubMed ID: 3191480
    [TBL] [Abstract][Full Text] [Related]  

  • 7. p21 ras protein expression in benign and malignant human breast.
    Walker RA; Wilkinson N
    J Pathol; 1988 Oct; 156(2):147-53. PubMed ID: 3058913
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Decreased expression of BRCA1 accelerates growth and is often present during sporadic breast cancer progression.
    Thompson ME; Jensen RA; Obermiller PS; Page DL; Holt JT
    Nat Genet; 1995 Apr; 9(4):444-50. PubMed ID: 7795653
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of all-trans-retinoic acid on c-fms proto-oncogene [colony-stimulating factor 1 (CSF-1) receptor] expression and CSF-1-induced invasion and anchorage-independent growth of human breast carcinoma cells.
    Sapi E; Flick MB; Tartaro K; Kim S; Rakhlin Y; Rodov S; Kacinski BM
    Cancer Res; 1999 Nov; 59(21):5578-85. PubMed ID: 10554038
    [TBL] [Abstract][Full Text] [Related]  

  • 10. neu and ras initiate murine mammary tumors that share genetic markers generally absent in c-myc and int-2-initiated tumors.
    Morrison BW; Leder P
    Oncogene; 1994 Dec; 9(12):3417-26. PubMed ID: 7970700
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression profiling of epithelial plasticity in tumor progression.
    Jechlinger M; Grunert S; Tamir IH; Janda E; Lüdemann S; Waerner T; Seither P; Weith A; Beug H; Kraut N
    Oncogene; 2003 Oct; 22(46):7155-69. PubMed ID: 14562044
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Wnt signalling in human breast cancer: expression of the putative Wnt inhibitor Dickkopf-3 (DKK3) is frequently suppressed by promoter hypermethylation in mammary tumours.
    Veeck J; Bektas N; Hartmann A; Kristiansen G; Heindrichs U; Knüchel R; Dahl E
    Breast Cancer Res; 2008; 10(5):R82. PubMed ID: 18826564
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human malignant tumours of the breast, as compared to their respective normal tissue, have elevated expression of the Harvey ras oncogene.
    Spandidos DA; Agnantis NJ
    Anticancer Res; 1984; 4(4-5):269-72. PubMed ID: 6207764
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aberrant expression of novel and previously described cell membrane markers in human breast cancer cell lines and tumors.
    Huang H; Groth J; Sossey-Alaoui K; Hawthorn L; Beall S; Geradts J
    Clin Cancer Res; 2005 Jun; 11(12):4357-64. PubMed ID: 15958618
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Growth factors and cancer.
    Goustin AS; Leof EB; Shipley GD; Moses HL
    Cancer Res; 1986 Mar; 46(3):1015-29. PubMed ID: 3002607
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Id4 messenger RNA and estrogen receptor expression: inverse correlation in human normal breast epithelium and carcinoma.
    de Candia P; Akram M; Benezra R; Brogi E
    Hum Pathol; 2006 Aug; 37(8):1032-41. PubMed ID: 16867866
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Blocking HER-2/HER-3 function with a dominant negative form of HER-3 in cells stimulated by heregulin and in breast cancer cells with HER-2 gene amplification.
    Ram TG; Schelling ME; Hosick HL
    Cell Growth Differ; 2000 Mar; 11(3):173-83. PubMed ID: 10768865
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of Wnt genes and frizzled 1 and 2 receptors in normal breast epithelium and infiltrating breast carcinoma.
    Milovanovic T; Planutis K; Nguyen A; Marsh JL; Lin F; Hope C; Holcombe RF
    Int J Oncol; 2004 Nov; 25(5):1337-42. PubMed ID: 15492823
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessment of c-erbB-2 amplification by immunohistochemistry in paraffin-embedded breast cancer.
    Kerns BJ; Jordan PA; Huper G; Marks JR; Iglehart JD; Layfied LJ
    Mod Pathol; 1993 Nov; 6(6):673-8. PubMed ID: 7905629
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Oncogene expression in colonic cancers].
    Höfler H
    Wien Med Wochenschr; 1988 Jun; 138(11-12):271-3. PubMed ID: 3051685
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.